GFM
WST icon

GF Fund Management’s West Pharmaceutical WST Stock Holding History

GF Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716K Buy
1,994
+21
+1% +$6.42K 0.01% 199
2026
Q1 		$495K Hold
1,973
– – 0.01% 217
2025
Q4 		$543K Sell
1,973
-36
-2% -$9.85K 0.01% 221
2025
Q3 		$527K Buy
2,009
+233
+13% +$56.6K 0.01% 223
2025
Q2 		$389K Sell
1,776
-13
-0.7% -$2.78K 0.01% 274
2025
Q1 		$401K Hold
1,789
– – 0.01% 272
2024
Q4 		$586K Buy
+1,789
New +$563K 0.01% 216

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GF Fund Management's WST Position: Q2 2026 in Review

GF Fund Management increased its West Pharmaceutical (WST) stake by 1.1% in Q2 2026, buying an estimated $6.42K and bringing the position to 1,994 shares worth $716K. The position accounts for 0.01% of the portfolio, ranked #199.

GF Fund Management first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • GF Fund Management held 1,994 shares of West Pharmaceutical worth $716K as of Q2 2026.
  • GF Fund Management bought 21 West Pharmaceutical shares in Q2 2026, an estimated $6.42K.
  • West Pharmaceutical made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #199 holding.
  • GF Fund Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.